Skip to main contentSkip to navigationSkip to search

Press releases and news

2022

Camurus’ Interim Report Third Quarter 2022

Camurus supports two Global Awareness Days for rare diseases

Camurus’ Nomination Committee appointed for the Annual General Meeting 2023

Camurus presenting five-year vision for growth and financial outlook at Capital Markets and R&D Day

Update of change in number of shares and votes in Camurus

Change in number of shares and votes in Camurus

Camurus supports International Overdose Awareness Day 2022

Program for Camurus’ Capital Markets and R&D Day 6 September 2022

Exercise of Camurus’ subscription warrant program 2019/2022

Camurus’ Interim Report Second Quarter 2022

Solasia acquires episil oral liquid business from Camurus

Change in number of shares and votes in Camurus

Camurus appoints Jonas Duborn as Head of Compliance

Invitation to Camurus’ Capital Markets and R&D Day 6 September 2022

Camurus to present at Jefferies 2022 Healthcare Conference New York

Change in number of shares and votes in Camurus

Resolutions at the annual general meeting 2022 in Camurus

Camurus' Interim Report January-March 2022

Camurus Annual Report for 2021

Notice of annual general meeting 2022 in Camurus AB (publ)

Load more press releases

Subscribe

Get the latest news from Camurus

Subscribe to receive latest news from Camurus directly to your email. 

Information types

By subscribing to news from Camurus, you agree to our privacy policy.

Thank you. You will get an e-mail message to activate your subscription.